tert-butyl 2-(aminomethyl)-1-azepanecarboxylate hydrochloride, 95.0%, 1g

N-(4-Chloro-3-(trifluoromethyl)phenyl)-4-methylbenzenesulfonamide, 95%, 2g

4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione>98.0%(HPLC)5mg

tert-Butyldimethyl((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)silane, 97%, 1g

4-Chlorobutanal dimethyl acetal, 97.0%, 1g

1-Propyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

N~3~,N~3~-dimethyl-1-phenyl-1,3-propanediamine dihydrochloride, 95.0%, 10g

5-Bromo-2-(methylsulfonyl)benzoic acid, 95+%, 100mg

5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline, 95.0%, 25g

4-Methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

6-Chloro-2-methoxynicotinaldehyde, 95.0%, 25g

Óxido de circonio(IV) en polvo 99,9% 5 micras 100 g

(4'-Methyl-[1,1'-biphenyl]-2-yl)methanamine, 95%, 500mg